Bonfiglio and colleagues obtained intensified PTX-3 signals in an environment with microcalcifications in comparison with those tissues without microcalcifications (collected from human breast biopsies), suggesting that PTX-3 could be used as a differentiation marker between malign and benign disease [49]. This evidence concerns the gene PTX3 and neoplasm.